Business

PAOG To Build On CBD Business Through Acquisition

PAOG To Build On CBD Business Through Acquisition.

articlePao Group, Inc.October 5, 20214/company/pao-group-inc/news/paog-to-build-on-cbd-business-through-acquisition
PAOG To Build On CBD Business Through Acquisition

About this update from Pao Group, Inc.

[{"type":"text","content":"\n\n\n\nPAOG To Build On CBD Business Through Acquisition\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPAOG To Build On CBD Business Through Acquisition\nPR Newswire\nSANDUSKY, OH, Oct. 5, 2021\n\n\n\nSANDUSKY, OH, Oct. 5, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced the company is actively exploring merger and acquisition opportunities targeted at expanding the company's product line and accelerating revenue growth.\nThe company recently announced initiating production on its first line of CBD nutraceuticals and being on track to generate its first revenue this year, in 2021, since entering the CBD market sector.\nPAOG is developing CBD pharmaceutical and nutraceuticals from its intellectual property associated with a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled \"METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.\"\nThe 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion, and it is expected to reach $16.4 Billion by 2027.\nPAOG plans to distribute its nutraceuticals through North American Cannabis Holdings, Inc. (USMJ).  PAOG has also entered into a marketing partnership with Puraiton, Inc. (PURA).\nPAOG's CBD nutraceutical developments stem from the company's long-term CBD pharmaceutical initiative built on a CBD intellectual property acquisition from Nouveau Life Pharmaceuticals (NOUV).\nPAOG's merger and acquisition objective is to complement its existing CBD intellectual property while diversifying its product production opportunity and accelerating the potential for rapid revenue growth.\nLearn more about PAOG at www.paogroupinc.com.\nForward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regardin...

More updates from Pao Group, Inc.